Reisz Pharmaceuticals Vital Care Inc is categorized under Recording Studios in Owensboro, KY and active since 1991.
Reisz Pharmaceuticals Vital Care Inc was established in 1991, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Recording Studios business, which does work in the B2B market, and is classified as a Recording Studios, under code number 512240 by the NAICS.
If you are seeking more information, feel free to contact Guy Reisz at the company’s single location by writing to 2315 Mayfair Drive # 18, Owensboro, Kentucky KY 42301 or by phoning (270) 688-0100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Reisz Pharmaceuticals Vital Care Inc |
| Contact Person: | Guy Reisz |
| Address: | 2315 Mayfair Drive # 18, Owensboro, Kentucky 42301 |
| Phone Number: | (270) 688-0100 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1991 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Recording Studios |
| SIC Code: | 7389 |
| NAICS Code: | 512240 |
| Share This Business: |
Reisz Pharmaceuticals Vital Care Inc was started in 1991 to provide professional Recording Studios under the SIC code 7389 and NAICS code 512240. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Guy Reisz for inquiries that concern Reisz Pharmaceuticals Vital Care Inc by calling the company number (270) 688-0100, as your correspondence is most welcome. Additionally, the physical location of the single location of Reisz Pharmaceuticals Vital Care Inc can be found at the coordinates 37.751368,-87.122798 as well as the street address 2315 Mayfair Drive # 18 in Owensboro, Kentucky 42301.
For its online presence, you may visit Reisz Pharmaceuticals Vital Care Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.